Tolerability of GalNAc
EVENT
Treatment with GalNAcThe mean percentage of injections leading to an LCRIS event was 2.2% with a median of 0%. The incidence of moderate or severe LCRIS, or LCRIS of any severity leading to discontinuation occurred in 8 (1.6%) of all ASO-treated subjects with a mean percentage of injections of 0.1% (